High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma
Status:
Recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This study was a multi-center, randomized, prospective study. The purpose is to clarify that
high-dose VP-16+G-CSF has better mobilization efficiency and less toxic and side effects
compared with high-dose CTX+G-CSF, and minimize mobilization failure, so as to provide
convenient and high-quality mobilization programs for clinical practice and enable more
patients to enter the transplantation stage smoothly.
Phase:
N/A
Details
Lead Sponsor:
Affiliated Hospital to Academy of Military Medical Sciences